摘要
目的探讨在瘢痕子宫中期妊娠应用药物引产的临床疗效。方法选取我院于2016年1月—2017年1月瘢痕子宫中期妊娠需进行流产的患者80例,随机分为两组,其中一组患者采用依沙吖啶羊膜腔注射,一组采用米索前列醇片,比较两组的引产成功率和不良事件发生率。结果两组患者在采用不同的引产药物之后,发现米索前列醇组中引产成功的有37例,成功率为92.5%,依沙丫啶组中引产成功的患者有38例,成功率为95.0%。在米索前列醇组中24 h分娩的患者有32例,48 h分娩的患者有5例,72 h分娩的患者有0例。依沙丫啶组中24 h分娩的患者有6例,48 h分娩的患者有28例,72 h分娩的患者有4例。米索前列醇组中不良反应事件发生率为47.5%,依沙丫啶组中总不良反应事件发生率为47.5%,两组在不良反应事件的发生率无明显差异。结论在瘢痕子宫妊娠引产药物中选择依沙吖啶和米索前列醇片安全性相似,功能效果一致,在临床上出现的不良反应事件也大致相同。
Objective To investigate the clinical efficacy of induced abortion with scar uterus in the second trimester. Methods 80 patients were randomly divided into two groups from January 2016 to January 2017. One group was treated with osacridine amniotic injection and the other group treated with misoprostol tablets. The success rate of induction and the incidence of adverse events were compared between the two groups. Results The results showed that there were 37 cases of successful induction of labor in the misoprostol group, and the success rate was 92.5%. There were 38 cases of success in the labor group,and the success rate was 95.0%. The incidence of adverse events in the misoprostol group was 47.5%, and the incidence of adverse events was 47.5% in the acacaline group. There was no significant difference in the incidence of adverse events between the two groups. Conclusion The safety of cisplatin and misoprostol tablets is similar in the scar uterine pregnancy induced drug, and the effect is similar. The adverse events are similar in the clinic.
出处
《中国卫生标准管理》
2017年第13期93-95,共3页
China Health Standard Management
关键词
瘢痕子宫
妊娠
引产
药物
scar uterus
pregnancy
induction of labor
drugs
